WELBIO is an inter-university life sciences research institute based in Wallonia, Belgium. WELBIO aims at promoting scientific excellence in fundamental life sciences research and translating scientific achievements in medical, pharmaceutical and veterinary biotechnology applications.

Annual Report 2016

In 2016, WELBIO supported twenty-two research programs through the Fund for Strategic Fundamental Research (F.R.S. (Fonds de la Recherche Scientifique) [Fund for Scientific Research]-FNRS) as well as three WELBIO Bridge Fund projects. These researches are, among others, carried out in the fields of neurobiology, genetic, immunology and cancer biology. Moreover, the new Board of Directors adopted its 2020 strategic plan, based on 4 main axes.

Inflammatory bowel disease: scientists zoom in on genetic culprits

In a study lead by Prof. Michel Georges (Welbio investigator at GIGA-Ulg), scientists examined the genome of 67,852 individuals and applied three statistical methods to zoom in on which genetic variants were actively implicated in the Inflammatory bowel disease. The results of this study were published in Nature.

Prof. Decio. Eizirik will present the keynote Ernst Knobil Lecture at the 38th IUPS

WELBIO is pleased to announce that Prof. Decio Eizirik, WELBIO investigator at the Université Libre de Bruxelles, has been invited to present the keynote Ernst Knobil Lecture at the 38th World Congress of the International Union of Physiological Sciences (IUPS-2017), to be held in Rio de Janeiro, Brazil, from August 1 to August 5, 2017.

All news

October 18, 2017 - 11:19 AM - URL: http://welbio.org/cms/c_8241/en/accueil